COMMUNIQUÉS West-GlobeNewswire

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
15/05/2025
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently [...]
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
15/05/2025
Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and [...]
Assemblée Générale Mixte du 11 juin 2025
15/05/2025
Châtillon, France, le 15 mai 2025 Assemblée Générale Mixte du 11 juin 2025 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – ISIN [...]
Combined General Meeting of June 11, 2025
15/05/2025
Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: [...]
Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
15/05/2025
Conference Call Scheduled for today, May 15, 2025, at 5:00pm ET. GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced [...]
Hapbee Technologies Teams Up with Liberty Alliance to Deliver Wearable Sleep and Performance Technology to the Defense Sector; Updates Status of Audited Financial Statements
15/05/2025
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF), a leading provider of wearable wellness technology, is proud to announce it has teamed up with Liberty [...]
Globus Medical Announces $500 Million Share Repurchase Program
15/05/2025
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up [...]
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
15/05/2025
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP ; [...]
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation
15/05/2025
$3 Million Lead Order from Strategic Investors Supports Bold Transformation VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“ Rakovina ” or the “ Company [...]
Shuttle Pharma Provides Corporate Update
15/05/2025
GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused [...]
Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update
15/05/2025
Conference call begins at 10:00 a.m. Eastern time on Friday, May 16, 2025 WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the [...]
BioSyent Declares Second Quarter 2025 Dividend
15/05/2025
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common [...]
BioSyent Releases Financial Results for First Quarter 2025
15/05/2025
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2025. Key highlights include: (CAD) Q1 [...]
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
16/05/2025
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook [...]
HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results
16/05/2025
MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel [...]
FuturHealth Under Review: Best GLP-1 Semaglutide Medication Prescription for Weight Loss with No Insurance
16/05/2025
Discover How FuturHealth’s Affordable Semaglutide Subscription Program Helps Users Lose Weight Without Insurance, Prescriptions, or Hassle—A Game-Changer in the GLP-1 Weight Loss Revolution San Diego, May 15, 2025 ( [...]
Ancient Biblical Remedies Under Review: Ancient Lost Remedies Revived with Hidden Healing Secret Remedies of the Scriptures
16/05/2025
365 Daily Health Unveils “The Encyclopedia of Natural Remedies” — A Faith-Based Digital Guide Reviving Ancient Biblical Remedies with Over 100 Scripture-Inspired Healing Practices for Holistic Wellness, Spiritual [...]
Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
15/05/2025
Biofrontera has received patent approval for the revised formulation of Ameluz ® , which extends patent protection through to December 2043 Ameluz PDT offers the potential for effective treatment of moderate to severe [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2025
15/05/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Pages